OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies
Kuldeep Dhama, Shailesh Kumar Patel, Mamta Pathak, et al.
Travel Medicine and Infectious Disease (2020) Vol. 37, pp. 101755-101755
Open Access | Times Cited: 180

Showing 26-50 of 180 citing articles:

Systemic Mycoses: A Potential Alert for Complications in COVID-19 Patients
Gonzalo Segrelles‐Calvo, Glauber Ribeiro de Sousa Araújo, Susana Frasés
Future Microbiology (2020) Vol. 15, Iss. 14, pp. 1405-1413
Closed Access | Times Cited: 64

CRISPR-Cas System: An Approach With Potentials for COVID-19 Diagnosis and Therapeutics
Prashant Kumar, Yashpal Singh Malik, Balasubramanian Ganesh, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 61

Plant-based vaccines and antibodies to combat COVID-19: current status and prospects
Kuldeep Dhama, Senthilkumar Natesan, Mohd. Iqbal Yatoo, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 12, pp. 2913-2920
Open Access | Times Cited: 55

Exploring the Potential of Carbon Dots to Combat COVID-19
Sabna Kotta, Hibah M. Aldawsari, Shaimaa M. Badr-Eldin, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 55

Feline infectious peritonitis (FIP) and coronavirus disease 19 (COVID‐19): Are they similar?
Saverio Paltrinieri, Alessia Giordano, Angelica Stranieri, et al.
Transboundary and Emerging Diseases (2020) Vol. 68, Iss. 4, pp. 1786-1799
Open Access | Times Cited: 54

Egypt's COVID-19 Recent Happenings and Perspectives: A Mini-Review
AbdulRahman A. Saied, Asmaa A. Metwally, Norah Madkhali, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 54

COVID-19 in the elderly people and advances in vaccination approaches
Kuldeep Dhama, Shailesh Kumar Patel, Senthilkumar Natesan, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 12, pp. 2938-2943
Open Access | Times Cited: 53

Global prevalence of prolonged gastrointestinal symptoms in COVID-19 survivors and potential pathogenesis: A systematic review and meta-analysis
Fauzi Yusuf, Marhami Fahriani, Sukamto S. Mamada, et al.
F1000Research (2021) Vol. 10, pp. 301-301
Open Access | Times Cited: 53

β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19
Niraj Kumar Jha, Charu Sharma, Hebaallah Mamdouh Hashiesh, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 53

Repurposing benzimidazole and benzothiazole derivatives as potential inhibitors of SARS-CoV-2: DFT, QSAR, molecular docking, molecular dynamics simulation, and in-silico pharmacokinetic and toxicity studies
Ranjan K. Mohapatra, Kuldeep Dhama, Amr Ahmed El‐Arabey, et al.
Journal of King Saud University - Science (2021) Vol. 33, Iss. 8, pp. 101637-101637
Open Access | Times Cited: 51

In silico studies on phytochemicals to combat the emerging COVID-19 infection
Mohnad Abdalla, Ranjan K. Mohapatra, Ashish K. Sarangi, et al.
Journal of Saudi Chemical Society (2021) Vol. 25, Iss. 12, pp. 101367-101367
Open Access | Times Cited: 50

The Immunopathology of COVID-19 and the Cannabis Paradigm
Nicole Paland, Antonina Pechkovsky, Miran Aswad, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 40

The Complexity of SARS-CoV-2 Infection and the COVID-19 Pandemic
Maria Karoliny da Silva Torres, Carlos David Araújo Bichara, Maria de Nazaré do Socorro de Almeida, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 30

The Impact of SARS-CoV-2 Infection on Youth Mental Health: A Narrative Review
Claudio Brasso, Silvio Bellino, Cecilia Blua, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 772-772
Open Access | Times Cited: 29

Klotho protein: A key modulator of aging and COVID-19 severity
Kiana Shahzamani, Atefeh Amooyi, Sajad Karampoor, et al.
International Journal of Biological Macromolecules (2025), pp. 139234-139234
Closed Access

Origin, evolution, and spread of SARS-CoV-2
Jonas Michel Wolf, Lucas Wolf, Paul C. Wolf, et al.
Elsevier eBooks (2025), pp. 5-19
Closed Access

Antiviral Activity of Water–Alcoholic Extract of Cistus incanus L.
Petya Angelova, Anton Hinkov, V. V. GERASIMOVA, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 947-947
Open Access

The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect
Alp Can, Hakan Coskun
Stem Cells Translational Medicine (2020) Vol. 9, Iss. 11, pp. 1287-1302
Open Access | Times Cited: 48

Nanotechnology-Based Approaches for the Detection of SARS-CoV-2
Ritika Gupta, Poonam Sagar, Nitesh Priyadarshi, et al.
Frontiers in Nanotechnology (2020) Vol. 2
Open Access | Times Cited: 46

Mental Health, Coping, and Social Support Among People Living with HIV in the Americas: A Comparative Study Between Argentina and the USA During the SARS-CoV-2 Pandemic
Deborah L. Jones, Jamile Ballivian, Violeta J. Rodriguez, et al.
AIDS and Behavior (2021) Vol. 25, Iss. 8, pp. 2391-2399
Open Access | Times Cited: 39

COVID-19: pathogenesis, advances in treatment and vaccine development and environmental impact—an updated review
Youssef A. Attia, Mohamed T. El‐Saadony, Ayman A. Swelum, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 18, pp. 22241-22264
Open Access | Times Cited: 39

A review on function and side effects of systemic corticosteroids used in high-grade COVID-19 to prevent cytokine storms.
Mohammad Amin Langarizadeh, Marziye Ranjbar Tavakoli, Ardavan Abiri, et al.
EXCLI journal (2021) Vol. 20, pp. 339-365
Closed Access | Times Cited: 37

Scroll to top